Clinical Trial Update: Epirubicin Hydrochloride, Cisplatin, and Fluorouracil or Capecitabine With or Without Lapatinib Ditosylate as First-Line Therapy in Treating Patients With Stomach Cancer or Gastroesophageal Junction Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial of Epirubicin hydrochloride, Cisplatin, and Fluorouracil or Capecitabine with or without Lapatinib for first-line treatment of gastric and gastroe…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Adenocarcinoma of the Gastroesophageal Junction
• Gastric Cancer

Drugs mentioned

• 5-Fluorouracil (5-FU)
• CISPLATIN (cisplatin)
• Capecitabine (capecitabine)
• Epirubicin hydrochloride (epirubicin hydrochloride)
• Lapatinib Ditosylate (lapatinib ditosylate)

Snippet

Sponsor: European Organisation for Research and Treatment of Cancer - EORTC | Conditions: Adenocarcinoma of the Gastroesophageal Junction, Gastric Cancer | Phase 2 | Status: TERMINATED